• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性神经外科疾病与损伤情况下凝血病的管理

Management of coagulopathy in the setting of acute neurosurgical disease and injury.

作者信息

Mathews Marlon, Newman Richard, Chappell E Thomas

机构信息

Department of Neurosurgery, University of California, Irvine, CA 92868, USA.

出版信息

Neurocrit Care. 2006;5(2):141-52. doi: 10.1385/NCC:5:2:141.

DOI:10.1385/NCC:5:2:141
PMID:17099261
Abstract

Blood coagulation and hemostasis issues are important aspects of patient care in acute neurosurgical patients. Coagulopathy often complicates the already difficult management of cerebrovascular and intracranial hemorrhagic disease and injuries, adding to the already high associated morbidity and mortality. Common causes of coagulopathy, as well as its management in acute neurosurgical settings, are outlined in this review. Awareness of how to promptly evaluate and effectively treat coagulopathic processes is instrumental to the success of the neurosurgeon in managing acute intracranial pathologies.

摘要

凝血和止血问题是急性神经外科患者护理的重要方面。凝血功能障碍常常使脑血管和颅内出血性疾病及损伤本就困难的管理变得更加复杂,进一步增加了已有的高发病率和死亡率。本综述概述了凝血功能障碍的常见原因及其在急性神经外科环境中的管理。了解如何及时评估和有效治疗凝血功能障碍过程对于神经外科医生成功处理急性颅内病变至关重要。

相似文献

1
Management of coagulopathy in the setting of acute neurosurgical disease and injury.急性神经外科疾病与损伤情况下凝血病的管理
Neurocrit Care. 2006;5(2):141-52. doi: 10.1385/NCC:5:2:141.
2
Hemostatic and hemorrhagic problems in neurosurgical patients.神经外科患者的止血和出血问题。
Acta Neurochir (Wien). 2009 Aug;151(8):873-900; discussion 900. doi: 10.1007/s00701-009-0409-z. Epub 2009 Jun 26.
3
Altered hemostasis: considerations for dental care.止血功能改变:牙科护理的注意事项。
J Calif Dent Assoc. 1995 Nov;23(11):41-54.
4
Coagulopathy: its pathophysiology and treatment in the injured patient.凝血功能障碍:其病理生理学及在创伤患者中的治疗
World J Surg. 2007 May;31(5):1055-64. doi: 10.1007/s00268-006-0653-9.
5
Hemostasis, coagulation abnormalities, and liver disease.止血、凝血异常与肝脏疾病。
Crit Care Nurs Clin North Am. 2013 Dec;25(4):435-46, v. doi: 10.1016/j.ccell.2013.09.001. Epub 2013 Oct 20.
6
Protocolised thromboelastometric-guided haemostatic management in patients with traumatic brain injury: a pilot study.创伤性脑损伤患者的血栓弹力描记术引导止血管理方案:一项初步研究。
Anaesthesia. 2019 Jul;74(7):883-890. doi: 10.1111/anae.14670. Epub 2019 Apr 29.
7
Transfusion strategies for traumatic coagulopathy.创伤性凝血病的输血策略。
Blood Rev. 2012 Sep;26(5):223-32. doi: 10.1016/j.blre.2012.06.004. Epub 2012 Jul 13.
8
Acute coagulopathy of trauma: mechanism, identification and effect.创伤性急性凝血病:机制、识别与影响
Curr Opin Crit Care. 2007 Dec;13(6):680-5. doi: 10.1097/MCC.0b013e3282f1e78f.
9
Acute traumatic coagulopathy: from endogenous acute coagulopathy to systemic acquired coagulopathy and back.急性创伤性凝血病:从内源性急性凝血病到全身性获得性凝血病,再回归本源。
J Trauma. 2011 May;70(5 Suppl):S47-9. doi: 10.1097/TA.0b013e31821a5c24.
10
Trauma-induced coagulopathy.创伤性凝血病
Crit Care Nurse. 2014 Aug;34(4):54-63. doi: 10.4037/ccn2014133.

引用本文的文献

1
Postoperative fibrinogen deficiency after surgical removal of intracranial tumors: Prevalence, risk factors and prognosis.颅内肿瘤切除术后的纤维蛋白原缺乏症:患病率、危险因素及预后
Surg Neurol Int. 2025 May 30;16:204. doi: 10.25259/SNI_125_2025. eCollection 2025.
2
Coagulopathy in the absence of overt DIC in postoperative neurosurgical patients is a strong predictor of poor outcome.术后神经外科患者在无明显弥散性血管内凝血情况下出现的凝血功能障碍是预后不良的有力预测指标。
Am J Blood Res. 2023 Aug 15;13(4):110-116. eCollection 2023.
3
Clinicopathological features and microsurgical outcomes for giant pediatric intracranial tumor in 60 consecutive cases.

本文引用的文献

1
Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death.原发性脑出血发病前规律使用阿司匹林是死亡的独立预测因素。
Stroke. 2006 Jan;37(1):129-33. doi: 10.1161/01.STR.0000196991.03618.31. Epub 2005 Dec 1.
2
Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage.抗血小板治疗会促使脑出血急性恶化。
Neurology. 2005 Oct 11;65(7):1000-4. doi: 10.1212/01.wnl.0000179178.37713.69.
3
Preoperative screening for coagulopathy using prothrombin time and partial thromboplastin time in patients requiring primary cranial vault remodeling.
60例儿童巨大颅内肿瘤的临床病理特征及显微手术结果
Childs Nerv Syst. 2017 Mar;33(3):447-455. doi: 10.1007/s00381-017-3341-1. Epub 2017 Feb 8.
4
Treatment of coagulopathy in intracranial hemorrhage.颅内出血的凝血障碍治疗。
Curr Treat Options Neurol. 2010 Mar;12(2):113-28. doi: 10.1007/s11940-010-0061-1.
5
Intensive care unit management of patients with stroke.脑卒中患者的重症监护病房管理。
Curr Treat Options Neurol. 2007 Nov;9(6):427-41. doi: 10.1007/s11940-007-0044-z.
在需要进行原发性颅盖重建的患者中,使用凝血酶原时间和部分凝血活酶时间进行凝血功能障碍的术前筛查。
Plast Reconstr Surg. 2005 Aug;116(2):389-94. doi: 10.1097/01.prs.0000172760.79803.68.
4
Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature.银杏叶相关的自发性出血:一例病例报告及文献系统综述:一例病例报告及文献系统综述。
J Gen Intern Med. 2005 Jul;20(7):657-61. doi: 10.1111/j.1525-1497.2005.0121.x.
5
The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults.血小板功能分析仪-100检测在儿童和成人止血缺陷的调查及管理中的作用。
Br J Haematol. 2005 Jul;130(1):3-10. doi: 10.1111/j.1365-2141.2005.05511.x.
6
Recombinant factor VIIa. An update on its clinical use.重组凝血因子VIIa。其临床应用的最新进展。
Thromb Haemost. 2005 Jun;93(6):1027-35. doi: 10.1160/TH05-01-0032.
7
Herbal medicines and postoperative haemorrhage.
Anaesthesia. 2005 Jul;60(7):725-6. doi: 10.1111/j.1365-2044.2005.04276.x.
8
Recombinant activated factor VII for acute intracerebral hemorrhage.重组活化凝血因子 VII 用于急性脑出血
N Engl J Med. 2005 Feb 24;352(8):777-85. doi: 10.1056/NEJMoa042991.
9
Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage.重组凝血因子VIIa用于急性颅内出血时华法林抗凝的快速逆转
Mayo Clin Proc. 2004 Dec;79(12):1495-500. doi: 10.4065/79.12.1495.
10
Hemostatic agents.
Transfusion. 2004 Dec;44(12 Suppl):58S-62S. doi: 10.1111/j.0041-1132.2004.04173.x.